Patents: From Invention to Commercialization in the Biomedical Space

The Office of Technology Commercialization
Presents

Invention 2 Innovation (I2I)

Patents: From Invention to Commercialization in the Biomedical Space

Wed., April 17, 2019
12:00 pm – 1:30 pm

Building D, Warwick Evans Conference Room (New Location)

Presented By

Dr. Ling Zhong, Ph.D., Shareholder

Dr. Ling Zhong, Ph.D., Shareholder

Mr. James M. Gould, Counsel

Mr. James M. Gould, Counsel   

Ratner Prestia

Recent legal developments are having a profound effect on critical patent issues in the biomedical space. This seminar will cover the latest trends and strategies including:

  • Patentability issues associated with inventions relating to biomarkers, diagnostics, new uses of known drugs, new formulations of known drugs, new dosage regimes, and new combinations
  • The interplay between patent-based exclusivity and the various FDA-based exclusivities
  • Patent issues arising from collaboration between inventors and sponsors of clinical trials